神經血管纏繞輔助設備的全球市場 - 市場規模(各市場區隔)，佔有率，法規和償付的形勢，治療，預測(～2033年)

本報告提供全球神經血管纏繞輔助設備市場相關調查分析，提供各市場區隔的市場規模，市場趨勢，競爭情形，COVID-19影響等資訊。

市場模式的主要的內容如下列。

目前上市的神經血管纏繞輔助設備和不斷變化的競爭格局

• 主要的產業趨勢考察
• 神經血管纏繞輔助設備市場區隔的年度收益和市場預測(2015年～2033年)
• 單位，平均銷售價格，市場金額相關市場層級的資料

世界，地區，國家層級的市場具體考察

• 各地區分類的定性市場具體資訊各國考察與全球趨勢
• 神經血管纏繞輔助設備市場SWOT分析
• 神經血管纏繞輔助設備市場競爭動態的考察和趨勢

透過取得真正的大局（包括醫療保健系統的概述）來促進對市場的了解。此外，市場准入部分可讓您透過有關報銷政策和監管環境的資訊更深入地了解市場動態。

• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規形勢

對象企業

• Stryker Corp
• MicroVention Inc
• Cerenovus
• Medtronic Plc
• Balt SAS
• 其他

Abstract

Neurovascular Coiling Assist Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Neurovascular Coiling Assist Devices market for the year 2020 and beyond. Neurovascular Coiling Assist Devices are used during coiling procedures to help hold coils in place as they are placed inside the aneurysm. Neurovascular Coiling Assist Devices can be coil assist stents or coil assist balloons. Neurovascular coiling assist device usage varies between countries, depending on the complexity of the case, costs and doctor's preference. There is a slightly higher usage of balloons over stents, however, this varies depending on the country. Some countries may opt to use balloons due to the lower cost of the device. The usage split between balloons and stents are expected to change from year to year depending on new technology and lower costs.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neurovascular Coiling Assist Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neurovascular Coiling Assist Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neurovascular Coiling Assist Devices market.
• Competitive dynamics insights and trends provided for Neurovascular Coiling Assist Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Stryker Corp, MicroVention Inc, Cerenovus, Medtronic Plc, Balt SAS and Others.

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neurovascular Coiling Assist Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Neurovascular Coiling Assist Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Neurovascular Coiling Assist Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Coiling Assist Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neurovascular Coiling Assist Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.